Arrowhead制药 ARWR 深 沪
等待开盘 07-30 09:30:00 美东时间
15.92
-0.280
-1.73%
华盛通- 最 高16.69
- 今 开16.56
- 成交量 159.78万股
- 最 低 15.82
- 昨 收 16.20
- 总市值 21.97亿
- 52周最高 27.34
- 市盈率 静 --
- 换手率 1.16%
- 52周最低 9.57
- 委 比 -67.18%
- 总股本 1.38亿
- 历史最高 93.66
- 量 比 0.66
- 振 幅 5.37%
- 历史最低 1.22
- 每 手 1
- 风险率 4.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sarepta Therapeutics Surges Over 40% In Tuesday Pre-Market: What's Going On?
Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug Administration's (FDA) recommendation to lift the voluntary hold on Elevidys, Sarepta's gene therapy for Duchenne Muscular Dystrophy.
07-29 17:41
FDA Probes Death Of 8-Year-Old Who Received Sarepta's Elevidys
FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy treatment.
07-28 20:48
Arrowhead Pharmaceuticals earns $100M milestone from Sarepta Therapeutics
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Monday announced that it has earned a $100 million milestone payment from Sarepta Therapeutics (NASDAQ:SRPT). The milestone was triggered when Arrowhead reached...
07-28 20:27
Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy
Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular dystrophy patients.
07-25 23:09
Arrowhead expects Sarepta to honor financial obligations
Arrowhead Pharmaceuticals (NASDAQ:ARWR) announced Wednesday that it expects its partner Sarepta Therapeutics (NASDAQ:SRPT), which recently withdrew its gene therapy Elevidys from the U.S. market, will...
07-23 22:25
Sarepta Reverses Course, Pauses Elevidys Shipments Amid FDA Safety Review
Sarepta pauses U.S. Elevidys shipments to complete FDA-requested safety label updates, aiming to resume distribution in the fourth quarter.
07-22 20:56
Arrowhead hits the skids due to partnership with Sarepta
Arrowhead Pharmaceuticals (NASDAQ:ARWR) is down ~22% since market close on July 18 and the reason could be that the company has several early-stage candidates in partnership with recently belaguered S...
07-21 23:58
Arrowhead Pharmaceuticals shares are trading higher after the company announced it has dosed the first patient for its YOSEMITE Phase 3 trial of RNAi-based Zodasiran.
Arrowhead Pharmaceuticals shares are trading higher after the company announced...
07-09 02:39
Pure Storage's new CFO gets praise from analysts
Pure Storage's (NYSE:PSTG) announcement on Tuesday that Tarek Robbiati will become its new Chief Financial Officer has received praise from some Wall Street analysts. Evercore ISI analyst Amit Daryan...
06-25 03:45
Pure Storage announces CFO appointment
Pure Storage (NYSE:PSTG) has named Tarek Robbiati as its new chief financial officer, effective immediately. Robbiati previously served as chief executive officer of RingCentral and CFO of Hewlett Pac...
06-24 21:09
